Acute and chronic caffeine administration differentially alters striatal gene expression in wild-type and adenosine A2A receptor-deficient mice

Synapse

Volumn 42, Issue 2, 2001, Pages 63-76

  Eastwood, Sharon L ^a   Burnet, Philip W J ^b   Gittins, Rebecca ^a   Baker, Kate ^a   Harrison, Paul J ^a  

^a WARNEFORD HOSPITAL   (United Kingdom)

^b RADCLIFFE INFIRMARY   (United Kingdom)

Author keywords

Dopamine; Enkephalin; GAD65; GAD67; In situ hybridization; Striatum; Substance P; Zif 268

Indexed keywords

8 CYCLOPENTYL 1,3 DIPROPYLXANTHINE; ADENOSINE A1 RECEPTOR; ADENOSINE A2A RECEPTOR; CAFFEINE; ENKEPHALIN; GENE PRODUCT; GLUTAMATE DECARBOXYLASE; ISOPROTEIN; NEUROPEPTIDE; OLIGONUCLEOTIDE; SUBSTANCE P;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN CORTEX; BRAIN REGION; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINERGIC ACTIVITY; GENE EXPRESSION REGULATION; HIPPOCAMPUS; IMAGE ANALYSIS; IMMEDIATE EARLY GENE; IN SITU HYBRIDIZATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; TRANSGENIC MOUSE;

ANIMALS; CAFFEINE; CYTOSKELETAL PROTEINS; DNA-BINDING PROTEINS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; EARLY GROWTH RESPONSE PROTEIN 1; ENKEPHALINS; GENE EXPRESSION REGULATION; GENES, IMMEDIATE-EARLY; GLUTAMATE DECARBOXYLASE; HIPPOCAMPUS; IMMEDIATE-EARLY PROTEINS; ISOENZYMES; MALE; MICE; MICE, KNOCKOUT; NEOSTRIATUM; NERVE TISSUE PROTEINS; NEUROPEPTIDES; PHOSPHODIESTERASE INHIBITORS; RECEPTOR, ADENOSINE A2A; RECEPTORS, PURINERGIC P1; RNA, MESSENGER; SOMATOSENSORY CORTEX; SUBSTANCE P; TRANSCRIPTION FACTORS; XANTHINES;

EID: 0034800956     PISSN: 08874476     EISSN: None     Source Type: Journal    
DOI: 10.1002/syn.1100     Document Type: Article

References (69)

1. Rescue of locomotor impairment in dopamine D2 receptor-deficient mice by an adenosine A2A receptor antagonist
2. Mice lacking the 65 kDa isoform of glutamic acid decarboxylase (GAD65) maintain normal levels of GAD67 and GABA in their brains but are susceptible to seizures
3. Both A1 and A2a purine receptors regulate striatal acetylcholine release
4. Structure of the NGFI-A gene and detection of upstream sequences responsible for its transcriptional induction by nerve growth factor
5. Selective attenuation of psychostimulant-induced behavioral responses in mice lacking A(2A) adenosine receptors
6. The role of the D2 dopamine receptor (D2R) in A2A adenosine receptor (A2AR)-mediated behavioral and cellular responses as revealed by A2A and D2 receptor knockout mice
7. Tachykinin (substance-P) gene expression in Leydig cells of the human and mouse testis
8. Caffeine-mediated induction of c-fos, zif-268 and arc expression through A1 receptors in the striatum: Different interactions with the dopaminergic system
9. Functional striatal hypodopaminergic activity in mice lacking adenosine A2A receptors
10. Concurrent elevation of the levels of expression of striatal preproenkephalin and preprodynorphin mRNA in the rat brain by chronic treatment with caffeine
11. Adenosine A1 and A2A receptor mediated control of proenkephalin and substance P mRNA expression in the rat striatum
12. The stimulant effects of caffeine on locomotor behaviour in mice are mediated through its blockade of adenosine A(2A) receptors
13. Postsynaptic dopamine/adenosine interaction. I. Adenosine analogues inhibit dopamine D2-mediated behaviour in short-term reserpinized mice
14. The striopallidal neuron: A main locus for adenosine-dopamine interactions in the brain
15. Molecular cloning of the rat A2 adenosine receptor: Selective co-expression with D2 dopamine receptors in rat striatum
16. Are methylxanthine effects due to antagonism of endogenous adenosine?
17. Actions of caffeine in the brain with special reference to factors that contribute to its widespread use
18. D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons
19. Dopamine differentially regulates dynorphin, substance P, and enkephalin expression in striatal neurons: In situ hybridization histochemical analysis
20. Behavioural effects of selective A2 adenosine receptor antagonists, CGS 21197 and CGS 22706, in mice
21. Adenosine receptor ligands: Differences with acute versus chronic treatment
22. Adenosine A1 receptors mediate hypoxia-induced inhibition of electrically evoked transmitter release from rat striatal slices
23. Effects of adenosine A1 and A2 receptor activation on electrically evoked dopamine and acetylcholine release from rat striatal slices
24. Effect of long term caffeine treatment on A1 and A2 adenosine receptor binding and on mRNA levels in rat brain
25. A1 and A2A adenosine receptors and A1 mRNA in mouse brain: Effect of long-term caffeine treatment
26. Adenosine A2A antagonist: A novel antiparkinsonian agent that does not provoke dyskinesia in parkinsonian monkeys
27. Molecular identification of the 67 kd form of glutamic acid decarboxylase from the mouse
28. Adenosine A2a receptor-mediated modulation of striatal [3H]GABA and [3H]acetylcholine release
29. Differential regulation of mRNA levels encoding for the two isoforms of glutamate decarboxylase (GAD65 and GAD67) by dopamine receptors in the rat striatum
30. Glutamate decarboxylase (GAD65) gene expression is increased by dopamine receptor agonists in a subpopulation of rat striatal neurons
31. Aggressiveness, hypoalgesia and high blood pressure in mice lacking the adenosine A2a receptor
32. The orphan receptor cDNA RDC7 encodes an A1 adenosine receptor
33. Arc, a growth factor and activity-regulated gene, encodes a novel cytoskeleton-associated protein that is enriched in neuronal dendrites
34. RDC8 codes for an adenosine A2 receptor with physiological constitutive activity
35. Differential effect of MK 801 and scopolamine on c-fos expression induced by L-dopa in the striatum of 6-hydroxydopamine lesioned rats
36. Behavioral effects of A1- and A2-selective adenosine agonists and antagonists: Evidence for synergism and antagonism
37. Adenosine A1 and A2 receptors modulate extracellular dopamine levels in rat striatum
38. Determination of the effects of caffeine and carbamazepine on striatal dopamine release by in vivo microdialysis
39. Evidence that adenosine A2 and dopamine autoreceptors antagonistically regulate tyrosine hydroxylase activity in rat striatal synaptosomes
40. Involvement of adenosine A2A receptors in the induction of c-fos expression by clozapine and haloperidol
41. Adenosine A2A receptor stimulation enhances striatal extracellular glutamate levels in rats
42. Receptors for purines and pyrimidines
43. Molecular cloning and characterization of a rat A1-adenosine receptor that is widely expressed in brain and spinal cord
44. Adenosine A2A receptor antagonists as new agents for the treatment of Parkinson's disease
45. Adenosine A2 receptors regulate the gene expression of striatopallidal and striatonigral neurons
46. A cloned G protein-coupled protein with a distribution restricted to striatal medium-sized neurons. Possible relationship with D1 dopamine receptor
47. Striatal restricted adenosine A2 receptor (RDC8) is expressed by enkephalin but not by substance P neurons: An in situ hybridization histochemistry study
48. Chronic caffeine alters the density of adenosine, adrenergic, cholinergic, GABA, and serotonin receptors and calcium channels in mouse brain
49. Effects of chronic caffeine on adenosine, dopamine and acetylcholine systems in mice
50. Visualisation of AMPA binding sites in the brain of mice lacking the adenosine A(2a) receptor
51. Adenosine as a neuromodulator
52. Adenosine receptors. Knockouts anxious for new therapy
53. Two isoforms of glutamate decarboxylase: Why?
54. Messenger RNAs encoding glutamate-decarboxylases are differentially affected by nigrostriatal lesions in subpopulations of striatal neurons
55. Molecular cloning and expression of the cDNA for a novel A2-adenosine receptor subtype
56. Regulation of rat cortex function by D1 dopamine receptors in the striatum
57. Biphasic changes in locomotor behavior and in expression of mRNA for NGFI-A and NGFI-B in rat striatum following acute caffeine administration
58. Increased expression of c-jun, junB, AP-1, and preproenkephalin mRNA in rat striatum following a single injection of caffeine
59. Antagonism of adenosine A2A receptors underlies the behavioural activating effect of caffeine and is associated with reduced expression of messenger RNA for NGFI-A and NGFI-B in caudate-putamen and nucleus accumbens
60. The stimulatory action and the development of tolerance to caffeine is associated with alterations in gene expression in specific brain regions
61. Regulation of the phosphorylation of the dopamine- and cAMP-regulated phosphoprotein of 32 kDa in vivo by dopamine D1, dopamine D2, and adenosine A2A receptors
62. Muscarinic receptors regulate striatal neuropeptide gene expression in normal and amphetamine-treated rats
63. The full D1 dopamine receptor agonist SKF-82958 induces neuropeptide mRNA in the normosensitive striatum of rats: Regulation of D1/D2 interactions by muscarinic receptors
64. Intrastriatal injection of a muscarinic receptor agonist and antagonist regulates striatal neuropeptide mRNA expression in normal and amphetamine-treated rats
65. Molecular and behavioral effects mediated by Gs-coupled adenosine A2a, but not serotonin 5-Ht4 or 5-Ht6 receptors following antipsychotic administration
66. Adenosine agonists can both inhibit and enhance in vivo striatal dopamine release
67. Molecular cloning and characterization of an adenosine receptor: The A3 adenosine receptor
68. Activation of mouse T-helper cells induces abundant preproenkephalin mRNA synthesis